603456 九洲药业
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额135,9471,824,246991,6551,360,3241,225,782
投资活动产生之现金流量净额(142,407)(2,032,100)(881,326)(1,056,803)(738,417)
筹资活动产生之现金流量净额38,770(912,713)(609,611)2,102,185(608,963)
汇率变动对现金及现金等价物的影响(18,500)(17,016)16,8957,60557,611
现金及现金等价物净增加/(减少)13,810(1,137,582)(482,387)2,413,311(63,987)
期初现金及现金等价物余额1,456,1002,593,6823,076,069662,759726,746
期末现金及现金等价物余额1,469,9101,456,1002,593,6823,076,069662,759